0.78 USD
▼-0.24-23.94%
盘后 0.79 +1.83%
2026-11-20
市值
$3.74M
市盈率
—
EPS
-2.31
股息率
—
52 周区间
0.75 – 2.54
成交量
93.13K
Beta
0.43
目标价
—
52W 低 0.7552W 高 2.54
价格走势
公司简介
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company’s pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer’s, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based th...